RCKT icon

Rocket Pharmaceuticals

146 hedge funds and large institutions have $1.85B invested in Rocket Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 55 increasing their positions, 49 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

less funds holding in top 10

Funds holding in top 10:

25% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 16

32% less capital invested

Capital invested by funds: $2.74B → $1.85B (-$888M)

Holders
146
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.68M
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$44.4M
2 +$24.1M
3 +$17.3M
4
NHAS
Novo Holdings A/S
Denmark
+$16M
5
Citadel Advisors
Citadel Advisors
Florida
+$15M

Top Sellers

1 -$39.8M
2 -$26.1M
3 -$15.5M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$14M
5
PA
Perceptive Advisors
New York
-$13.2M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$287K
102
$286K
103
$285K
104
$271K
105
$269K
106
$259K
107
$259K
108
$256K
109
$245K
110
$245K
111
$233K
112
$227K
113
$224K
114
$216K
115
$198K
116
$140K
117
$135K
118
$127K
119
$115K
120
$102K
121
$90K
122
$90K
123
$67K
124
$62K
125
$54K